Blog, 2021

ChemDiv shares reviews on Nature and Science Journal articles that we found the most exciting this month. Here is the first part of the July reviews. Today we observe Genetic Engineering, Drug res...

We share reviews on Nature and Science Journal articles that we found the most interesting this month. Here is the second part of the June reviews. Today we observe neurophysiology, drug research,...

ChemDiv follows trends in biology and chemistry to supply clients with high scientific and up-to-date service. We will share reviews on Nature and Science Journal articles that we found the most i...

ChemDiv has been selected as a discovery partner with Gwynant Therapeutics and Celyn Therapeutics and starts to work on novel small molecules for oncology targets.

ChemDiv,Inc.

Combinatorial libraries: from ligand-receptor recognition to machine-learning

These are ChemDiv's reviews on Nature and Science Journal articles.

ChemDiv presets a brand new OCULAR DISEASES SMALL MOLECULES LIBRARY (13,000 compounds, 7 targets, 4 diseases)For design of screening library we use emerging Targets.

In people with sickle cell disease, the structure of hemoglobin, a protein of red blood cells that carries oxygen, is disrupted. Due to a hereditary mutation in such people, hemoglobin does not assemb...

Here are ChemDiv's reviews on Nature and Science Journal articles.

                            The XXVI EFMC International Symp...

Diabetes mellitus was a fatal disease for humans 100 years ago. Its development of begins with the fact that the child’s immunity after some trigger (stress, illness) starts to damage his beta-c...